<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01897103</url>
  </required_header>
  <id_info>
    <org_study_id>12-03123</org_study_id>
    <nct_id>NCT01897103</nct_id>
  </id_info>
  <brief_title>Platelet Activity in Vascular Surgery for Thrombosis and Bleeding</brief_title>
  <acronym>PIVOTAL</acronym>
  <official_title>Platelet Activity in Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers
      during the perioperative period. The goal is to develop a clinically useful assessment of
      platelet/coagulation activity for risk stratification that may ultimately serve as a target
      for therapeutic intervention. This study will enroll 200 patients with peripheral artery
      disease undergoing vascular surgery. PIVOTAL is funded by American Heart Association and is
      scheduled to begin enrollment in July 2013 for approximately two years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To describe platelet activity among PAD subjects undergoing vascular surgery.

      To determine whether preoperative platelet activity measurements are independently associated
      with perioperative cardiovascular events.

      To identify demographic, clinical, and surgical factors associated with postoperative
      platelet activity measurements in patients with established PAD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet Activity</measure>
    <time_frame>two years</time_frame>
    <description>The main outcome measures are platelet activity, coagulation markers, platelet mapping and profiling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative Events</measure>
    <time_frame>Two-years</time_frame>
    <description>Thrombotic and Bleeding events</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Peripheral Vascular Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Carotid Stenosis</condition>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Aortic Aneurysm, Thoracic</condition>
  <condition>Amputation, Wound</condition>
  <condition>Embolism and Thrombosis</condition>
  <condition>Aortic Aneurysm</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, plasma, platelet RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study Population will be selected from the inpatient setting at NYU Medical Center and
        Bellevue Hospital as well as the outpatient setting in the Faculty Group Practice.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects undergoing non emergent vascular surgery

          -  Use of aspirin within 48 hours prior to surgery

          -  Age &gt; 21 years of age

          -  Able and willing to provide written informed consent for the study

        Exclusion Criteria:

          -  Use of any anticoagulant (Coumadin, heparin) within 24 hours to surgery

          -  Use of any Nonsteroidal Antiinflammatory Drug (NSAID) (such as ibuprofen, naproxen,
             etc.) within 72 hours

          -  Thrombocytopenia (platelet count&lt;100) or Thrombocytosis (platelet count&gt;500),

          -  Anemia (hemoglobin&lt;9),

          -  Severe kidney disease (CrCl&lt;30ml/min),

          -  Any known hemorrhagic diathesis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey S Berger, MD, MS, FAHA, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bellevue Hospital Center, South Manhattan Healthcare Network</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University School Of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berger JS, Hiatt WR. Medical therapy in peripheral artery disease. Circulation. 2012 Jul 24;126(4):491-500. doi: 10.1161/CIRCULATIONAHA.111.033886. Review.</citation>
    <PMID>22825411</PMID>
  </reference>
  <reference>
    <citation>Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost. 2013 Jan;109(1):85-92. doi: 10.1160/TH12-03-0202. Epub 2012 Dec 6.</citation>
    <PMID>23223800</PMID>
  </reference>
  <reference>
    <citation>Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010 Jan;8(1):148-56. doi: 10.1111/j.1538-7836.2009.03584.x. Epub 2009 Aug 19. Review.</citation>
    <PMID>19691485</PMID>
  </reference>
  <reference>
    <citation>Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014 Jun;21(6):704-11. doi: 10.1177/2047487312452968. Epub 2012 Jun 27.</citation>
    <PMID>22739687</PMID>
  </reference>
  <reference>
    <citation>Sharma G, Berger JS. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. J Thromb Thrombolysis. 2011 Aug;32(2):201-8. doi: 10.1007/s11239-011-0590-9. Review.</citation>
    <PMID>21562837</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2013</study_first_submitted>
  <study_first_submitted_qc>July 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2013</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peripheral Artery Disease</keyword>
  <keyword>Endarterectomy (Carotid)</keyword>
  <keyword>Aortic Aneurysm, Abdominal</keyword>
  <keyword>Aortic Aneurysm, Thoracic</keyword>
  <keyword>Amputation</keyword>
  <keyword>Platelet Activity</keyword>
  <keyword>Thrombin</keyword>
  <keyword>Transcriptomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Embolism and Thrombosis</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

